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Role of ICT and eHealth in diabetic pregnancy
Pregnant women with diabetes require frequent contact with their clinicians in an attempt to achieve
normoglycaemia. With increasing numbers of women diagnosed with diabetes in pregnancy, particularly
gestational diabetes, the demand on health services and the budgetary impact, particularly on health care
practitioner time, will be significant. Healthcare resources are finite so it is incumbent on the clinical and
research community to develop programmes which can deliver healthcare more effectively and efficiently.
eHealth has been proposed as a potential solution which could minimise the burden of disease on health-
care providers, and the system as a whole, while at the same time increasing access to and efficiency of
care.
eHealth is the use of information and communication technologies (ICT) for health and is one of the most
rapidly growing areas in health today. eHealth includes infrastructural arrangements such as regional health
networks and electronic patient records systems as well as telemedicine. Telemedicine literally translated
means “healing at a distance”. Rather than being a single technology, telemedicine is part of a wider process
or chain of care. Its distinguishing feature is the reliance on ICT as a substitute for personal contact between
participants. Telemedicine covers a wide range of activities including diagnosis, treatment and prevention of
disease and injuries, research and evaluation and education of health care providers. There are numerous
telemedicine programmes worldwide covering virtually every medical speciality. Most serve people in rural
areas or the elderly in their homes.
In the care of those with diabetes telemedicine has been used for retinopathy screening, patient education,
ulcer management and interventions to improve diet, increase physical activity and encourage weight loss.
The most frequent use of telemedicine in diabetes however has been for the transmission of blood glucose
values from the patient to their health care provider. Telemedicine tends to be used in this way in an attempt
to improve the impact of self-monitoring of blood glucose (SMBG), to make SMBG more compatible with the
patient’s lifestyle and to engage patients more in their own care. As per telemedicine in diabetes generally,
the most common use for telemedicine in pregnancy affected by diabetes has been for transmission of
SMBG values. This has been done with the aim of facilitating increased frequency of review, reducing the
need for such frequent face-to-face review and enabling faster transmission of SMBG values to the health
care team.
This presentation will set the scene relating to the use of telemedicine in diabetic pregnancy. It will discuss
the findings from Tele-Mum , a feasibility study for a randomised controlled trial, conducted to determine the
feasibility and acceptability of using telemedicine in the diabetes care of those with gestational diabetes and
to ultimately replace alternate diabetes review clinics with telemedicine review. Patient and staff perspectives
of using telemedicine will be discussed along with the broader challenges encountered when implementing
and evaluating telemedicine services. As this was a feasibility study it was not powered to detect significant
differences however, the process of study set up, staff training, engagement with industry and multi-site trial
design led to considerable learning and insight in addition to the measured outcomes.
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Conclusions to be raised as discussion points include that; the women in the study were pleased to able to
reduce clinic attendance through tele-monitoring but were also reassured that face-to-face contact was still
available as a ‘safety net’, that in rural areas the ICT infrastructure may not be sufficiently reliable to support
remote monitoring, that the devices and services offered by industry are rapidly changing and gathering
evidence to support their application in practice is a challenge not least due to ambiguity surrounding
identification of the most appropriate outcome measures. While eHealth can make a valuable contribution to
the management of diabetic pregnancy it should not be viewed as a simple, cheap, panacea to overcome all
the issues raised in the introduction.
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